Michael Tardugno - Aug 4, 2025 Form 4 Insider Report for Imunon, Inc. (IMNN)

Role
Executive Chairman of Board, Director
Signature
/s/ Susan Eylward, Attorney-in-Fact for Michael Tardugno
Stock symbol
IMNN
Transactions as of
Aug 4, 2025
Transactions value $
$0
Form type
4
Date filed
8/6/2025, 04:23 PM
Previous filing
Mar 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tardugno Michael H Executive Chairman of Board, Director C/O IMUNON, INC., 997 LENOX DRIVE, SUITE 100, LAWRENCEVILLE /s/ Susan Eylward, Attorney-in-Fact for Michael Tardugno 2025-08-06 0001384550

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNN Stock Option (Right to Buy) Award $0 +1.67K $0.00 1.67K Aug 4, 2025 Common Stock 1.67K $9.20 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the closing price of Imunon, Inc. Common Stock on the date of the grant
F2 The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

Remarks:

On July 25, 2025, the Issuer effected a reverse stock split of Issuer Common Stock at a ratio of 1-for-15 (the "Reverse Stock Split"). As a result of the Reverse Stock Split, the shares of Issuer Common Stock, and the exercise price and shares of Issuer Common Stock underlying outstanding equity awards, have been adjusted accordingly versus any amounts previously reported by the Reporting Person.